文献速递神经介入DSA

低剂量数字减影血管造影方案用于颅内硬脑膜动静脉瘘血管内治疗的可行性

Feasibility of low-dose digital subtraction angiography protocols for the endovascular treatment of intracranial dural arteriovenous fistulas.
PubMed 文献 · Neuroradiology · 2020-08-28

本研究纳入2014年1月至2018年7月接受血管内治疗的55例颅内硬脑膜动静脉瘘患者,比较2016年1月起采用低剂量DSA方案的低剂量组(n=27)与2016年1月前采用常规剂量方案的常规剂量组(n=28)。低剂量组总KAP降低40.1%(87.9 vs 146.7 Gy cm2,p=0.002),两组DSA造影次数与透视时间相似,治疗结局无显著组间差异,低剂量组有1例(1.8%)操作相关并发症。作者认为低剂量方案可行,可显著降低辐射剂量且操作结局可接受。

要点

  • 低剂量组总KAP为87.9 Gy cm2,常规剂量组为146.7 Gy cm2,低剂量组降低40.1%(p=0.002)。
  • 两组平均DSA造影次数(25.1 vs 25.5,p=0.86)与透视时间(77.4 vs 69.7 min,p=0.48)相似。
  • 低剂量组有1例(1.8%)操作相关并发症,除1例外的患者临床结局良好(改良Rankin评分≤2)。

核心结论

  • 低剂量DSA方案用于颅内硬脑膜动静脉瘘栓塞治疗可行,可显著降低辐射剂量且操作结局可接受。

研究设计与样本

  • 单中心研究,纳入2014年1月至2018年7月接受血管内治疗的55例颅内硬脑膜动静脉瘘患者。
  • 低剂量组(n=27)自2016年1月起纳入,采用通过修改铜滤过厚度或探测器入射剂量制成的多种低剂量DSA方案。
  • 常规剂量组(n=28)为2016年1月前纳入的病例。
  • 比较辐射剂量指标(air-kerma、KAP、透视时间)以及临床和影像结局。

诊断标准与关键数值

  • 即刻良好闭塞率(完全或近完全闭塞)在41例(74.5%)患者中实现。
  • 10例(18.2%)患者因残留(n=6)和/或复发(n=5)病灶接受额外操作。
  • 中位随访10个月时,45例(86.5%)患者达到良好闭塞。

临床应用与阅片要点

  • 低剂量DSA方案通过修改铜滤过厚度或探测器入射剂量实现,用于颅内硬脑膜动静脉瘘栓塞治疗时可显著降低总KAP。
  • 低剂量组总KAP为87.9 Gy cm2,常规剂量组为146.7 Gy cm2,低剂量组降低40.1%(p=0.002)。
  • 两组治疗结局无显著组间差异,低剂量组有1例(1.8%)操作相关并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Among neurointerventional procedures, the embolization of complex shunt lesions usually requires more radiation dose. We aimed to evaluate the procedural outcome and safety in using low-dose DSA protocols for intracranial dural arteriovenous fistula (AVF) embolization treatment.

METHODS: Between January 2014 and July 2018, 55 patients with dural AVFs who underwent endovascular treatment were included in the study. The low-dose group (n = 27) included from January 2016 used various low-dose DSA protocols made by modifying the thickness of the copper filter or the detector entrance dose. We compared radiation dose metrics, such as air-kerma, kerma-air product (KAP), and fluoroscopy time, as well as clinical and imaging outcomes with the conventional-dose group (n = 28) included before January 2016.

RESULTS: The total KAP was 40.1% lower in the low-dose group (87.9 vs. 146.7 Gy cm2, p = 0.002). The average number of DSA runs (25.1 vs. 25.5, p = 0.86) and fluoroscopy times (77.4 vs. 69.7 min, p = 0.48) were similar between the groups. An immediate favorable occlusion rate (total or near total occlusion) was achieved in 41 (74.5%) patients. Ten patients (18.2%) underwent additional procedures due to residual (n = 6) and/or recurrent (n = 5) lesions. At a median of 10 months follow-up, 45 patients (86.5%) had achieved favorable occlusion. Treatment outcomes showed no significant between-group differences. There was one case (1.8%) of procedure-related complications in the low-dose group. All but one patient showed favorable clinical outcomes (modified Rankin score ≤ 2).

CONCLUSION: The low-dose protocols were feasible by showing significant radiation dose reduction and acceptable procedural outcome.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Song Y, Han S, Kim BJ, et al. Feasibility of low-dose digital subtraction angiography protocols for the endovascular treatment of intracranial dural arteriovenous fistulas. Neuroradiology. 2020. PMID: 32857215. doi:10.1007/s00234-020-02537-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。